Idiopathic intracranial hypertension (IIH): shunting
Evidence-based neurology checklist on idiopathic intracranial hypertension (iih): shunting: Indications Reduced visual acuity at onset Progressive visual loss Severe (high-grade) papilloedema Malignant IIH: rapid visual decline Atrophic papilloedema Recent weight gain Hypertension Subretinal…
Indications
- Reduced visual acuity at onset
- Progressive visual loss
- Severe (high-grade) papilloedema
- Malignant IIH: rapid visual decline
- Atrophic papilloedema
- Recent weight gain
- Hypertension
- Subretinal haemorrhage
Benefits
Protocol
Complications
References
- Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuro Ophthalmol 2004; 24:138-145.
- Wall M, Falardeau J, Fletcher WA, et al; NORDIC Idiopathic Intracranial Hypertension Study Group. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Neurology 2015; 85:799-805.
- Sinclair AJ, Kuruvath S, Sen D, Nightingale PG, Burdon MA, Flint G. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia 2011; 31:1627-1633.
- Mollan SP, Davies B, Silver NC, et al. Idiopathic intracranial hypertension: consensus guidelines on management. JNNP 2018; 89:1088-1100.
- Brune AJ, Girgla T, Trobe JD. Complications of ventriculoperitoneal shunt for idiopathic intracranial hypertension: a single-institution study of 32 patients. J Neuroophthalmol 2021; 41:224-232.
Related checklists
- Idiopathic intracranial hypertension (IIH): MRI features
- Idiopathic intracranial hypertension (IIH): lumbar puncture
- Idiopathic intracranial hypertension (IIH): other investigations
- Idiopathic intracranial hypertension (IIH): medical treatment
- Idiopathic intracranial hypertension (IIH): headache-specific treatments
- Idiopathic intracranial hypertension (IIH): dural venous sinus stenting (DVSS)
- Idiopathic intracranial hypertension (IIH): other surgical treatments
